XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common Stock Shares Outstanding
Common Stock
Additional Paid-In Capital
Accum. Other Comp. Income Gain Agency MBS
Accum. Other Comp. Income Non-Agency MBS
Accum. Other Comp. Gain (Loss) Derivatives
Accum. (Deficit)
Series A Preferred Stock
Accum. (Deficit)
Series C Preferred Stock
Accum. (Deficit)
Series B Preferred Stock
Accum. (Deficit)
Series A Preferred Stock Shares Outstanding
Series C Preferred Stock Shares Outstanding
Series A Preferred Stock
Series C Preferred Stock
Series B Preferred Stock
Total
Beginning Balance at Dec. 31, 2016   $ 957 $ 966,714 $ 24,869 $ 1,536 $ (17,757)       $ (403,079)     $ 46,537 $ 11,321   $ 631,098
Beginning Balance (in shares) at Dec. 31, 2016 95,718,000                   1,919,000 486,000        
Issuance of stock   1 320                     4,854   5,175
Issuance of stock (in shares) 61,000                     197,000        
Cancellation of common stock   (2) 2                          
Cancellation of common stock (in shares) (197,000)                              
Other comprehensive income, fair value adjustments and reclassifications       2,403 9,514 614                   12,531
Net income                   15,401           15,401
Amortization of restricted stock     20                         20
Dividend declared             $ (1,035) $ (253) $ (394)       (1,035) (253) $ (394)  
Dividend declared - $0.15 per common share                   (14,337)           (14,337)
Ending Balance at Mar. 31, 2017   956 967,056 27,272 11,050 (17,143)       (403,697)     46,537 16,175   648,206
Ending Balance (in shares) at Mar. 31, 2017 95,582,000                   1,919,000 683,000        
Beginning Balance at Dec. 31, 2016   957 966,714 24,869 1,536 (17,757)       (403,079)     46,537 11,321   631,098
Beginning Balance (in shares) at Dec. 31, 2016 95,718,000                   1,919,000 486,000        
Other comprehensive income, fair value adjustments and reclassifications                               16,992
Net income                               25,498
Dividend declared                               (3,780)
Ending Balance at Jun. 30, 2017   975 976,482 22,350 19,869 (16,579)       (410,254)     46,537 38,240   677,620
Ending Balance (in shares) at Jun. 30, 2017 97,498,000                   1,919,000 1,580,000        
Beginning Balance at Mar. 31, 2017   956 967,056 27,272 11,050 (17,143)       (403,697)     46,537 16,175   648,206
Beginning Balance (in shares) at Mar. 31, 2017 95,582,000                   1,919,000 683,000        
Issuance of stock   1 307                 $ 897   22,065   22,373
Issuance of stock (in shares) 53,000                              
Conversions of Series B Preferred Stock   18 9,099                         $ 9,117
Conversions of Series B Preferred Stock (in shares) 1,863,000                             1,862,880
Other comprehensive income, fair value adjustments and reclassifications       (4,922) 8,819 564                   $ 4,461
Net income                   10,097           10,097
Amortization of restricted stock     20                         20
Dividend declared             $ (1,035) $ (751) $ (244)       (1,035) (751) $ (244) (2,025)
Dividend declared - $0.15 per common share                   (14,624)           (14,624)
Ending Balance at Jun. 30, 2017   $ 975 $ 976,482 $ 22,350 $ 19,869 $ (16,579)       $ (410,254)     $ 46,537 $ 38,240   $ 677,620
Ending Balance (in shares) at Jun. 30, 2017 97,498,000                   1,919,000 1,580,000